Nightingale partners with Coronaria for healthcare pilot

This month sees the beginning of our technology healthcare pilot. The goal of this pilot, in partnership with  Finnish health service provider  Coronaria,  is to  verify  that  Nightingale’s blood analysis service  can be successfully applied within a  healthcare setting.  

Nightingale's blood test  can  replace  many  routine  blood tests  currently used in healthcare  (e.g.  glucose), along with  providing other blood biomarkers  that  can  enhance disease risk  prediction.  In the  long-term, Nightingale  plans to  provide better tools  for  clinicians,  enabling  preventive healthcare for  chronic diseases,  such as  diabetes and cardiovascular disease.    

"The only sustainable way to reduce the burden of chronic diseases is to invest in their prevention. The goal of this cooperative  pilot with  Coronaria  is to prove Nightingale's technology's suitability  for  routine  clinical  use," says Nightingale Health's CEO  Teemu  Suna.   

The pilot's cooperative partner  Coronaria  is one of Finland's largest providers of healthcare services.   

"Coronaria  aims to  build a novel healthcare system  in  Finland  that will benefit  all  of us, with  patients receiving  better care, personnel  achieving more and  society saving  money. The emphasis  in healthcare  must be shifted to preventive and  personalized  care, especially  for  chronic disease  treatments. We see Nightingale's blood analysis as  an  important tool to achieve this  goal.  As a result, we wanted  to be  the  first  to  pilot the service in Finland", says  Olli  Karhi, member of the board of Cor Group.